SCHEMBL6000646

SCHEMBL6000646

CCCC(CCC)c1ccc(OCc2ccc(-c3csc(CN(CC(=O)O)Cc4nc5ccccc5[nH]4)c3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.51
PTPN2 P17706 1/20 0.51
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
HTT P42858 1/20 0.39
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
PTGES O14684 1/20 0.37
DHODH Q02127 2/20 0.37
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000614 0.88 PTPN1 (0.51) PTPN1PTPN2TDP1NPC1RAB9A
SCHEMBL6000201 0.88 PTPN1 (0.67) PTPN1PTPN2TDP1NPC1RAB9A
SCHEMBL6000462 0.86 PTPN1 (0.46) PTPN1PTPN2DHODHFFAR1
Hydrochloric Acid SCHEMBL6000739 0.86 PTPN1 (0.45) PTPN1PTPN2DHODHFFAR1
SCHEMBL6000830 0.85 PTPN2 (0.52) PTPN1PTPN2CYSLTR1FFAR1
SCHEMBL6000597 0.85 PTPN2 (0.59) PTPN1PTPN2TDP1NPC1RAB9A
Sulfuric Acid SCHEMBL6000131 0.84 PTPN1 (0.44) PTPN1PTPN2DHODHMMP13FFAR1
SCHEMBL6000456 0.83 PTPN2 (0.52) PTPN1PTPN2NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL6000734 0.83 PTPN2 (0.52) PTPN1PTPN2NPC1RAB9ASMN1; SMN2
SCHEMBL6000193 0.82 PTPN1 (0.52) PTPN1PTPN2PPARGPPARAMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN1 2/4885PTPN2 11/4885TDP1 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.